DE HB166

Mandates blood lead level screening (capillary blood test) for all children at or around 12 and 24 months of age by their primary healthcare provider.

Defines "screening" as capillary blood lead tests and "testing" as venous blood lead tests, with healthcare providers encouraged to use clinical judgment to determine when testing should be used instead of screening.

Requires child care facilities, preschools, and kindergartens to obtain proof of lead poisoning screening for enrollment or continued enrollment of children 12 months and older.

Ensures health insurance policies, both individual and group/blanket coverage, must reimburse for baseline lead poisoning screening and testing at 12 months of age, plus diagnostic evaluations and supplies for high-risk children under age 6.

Directs the Division of Public Health to promulgate implementation and enforcement regulations within 12 months and report annually to the General Assembly on elevated blood lead levels in children.